Patients who should wait before starting BPC-157: those with active malignancy or a personal history of hormone-sensitive cancer, pregnant patients, and anyone who has not yet completed a basic anti-inflammatory protocol for an acute injury
Key Features and Benefits Dual Peptide Synergy: Combines BPC-157 and TB-500 for advanced research applications
If a diagnosis was not declared, a potential participant could not continue
Further Reading: Guide to Gym Supplements Studies into this peptide cancelled or stopped without any published results, so conclusions havent been made into what BPC-157 does for the body, but as mentioned, it was originally experimented on as a compound to help with inflammatory bowel disease and soft tissue healing
Book your appointment online and complete a short medical questionnaire
J.KnstlerA.JuhszC.Daz-VivancosP.et al